Author

Jordina Llaó

Observed names: J LLaó, J Llao, J Llao Guardia, J Llaó, J. Llao, J. Llao Guardia, J. Llaó, J. Llaó Guardia, J. Llaό, Jordina LLaó, Jordina Llao, Jordina Llaó Guàrdia, Jordina Llaó-Guàrdia, Llao, J., Llaó Jordina, Llaó, Jordina

Institutions: Althaia, Hospital Universitari Germans Trias i Pujol

Observed institutions: Universitat Autònoma de Barcelona, Hospital de Sant Pau, Bellvitge University Hospital, Universitat Internacional de Catalunya, Althaia, Hospital Clínic de Barcelona, Vall d'Hebron Hospital Universitari, Mútua Terrassa, Hospital Del Mar, Hospital de Cruces, Hospital Universitari Germans Trias i Pujol, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Hospital Universitario Infanta Leonor, Universitat de Barcelona

OpenAlex ID: A5111827789

Accuracy of the Narrow-Band Imaging International Colorectal Endoscopic Classification System in Identification of Deep Invasion in Colorectal Polyps

2018 · Ignasi Puig, María López-Cerón, et al. · Gastroenterology · 116

Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study

2016 · M J Casanova, M Chaparro, et al. · The American Journal of Gastroenterology · 114

PDF

Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry

2020 · María Chaparro, Ana Garre, et al. · Journal of Crohn s and Colitis · 107

PDF

Prevalence and Factors Associated With Fatigue in Patients With Inflammatory Bowel Disease: A Multicentre Study

2019 · C Chavarría, M J Casanova, et al. · Journal of Crohn s and Colitis · 107

Short and long‐term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry

2018 · María Chaparro, Ana Garre, et al. · Alimentary Pharmacology & Therapeutics · 107

PDF

How and When Should NSAIDs Be Used for Preventing Post-ERCP Pancreatitis? A Systematic Review and Meta-Analysis

2014 · Ignasi Puig, Xavier Calvet, et al. · PLoS ONE · 83

PDF

Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry

2019 · María José Casanova, María Chaparro, et al. · Inflammatory Bowel Diseases · 54

PDF

Early treatment with anti‐tumor necrosis factor agents improves long‐term effectiveness in symptomatic stricturing Crohn’s disease

2020 · Iago Rodríguez‐Lago, Javier Del Hoyo, et al. · United European Gastroenterology Journal · 48

Post-Operative Morbidity and Mortality of a Cohort of Steroid Refractory Acute Severe Ulcerative Colitis: Nationwide Multicenter Study of the GETECCU ENEIDA Registry

2018 · I Ordás, E Domènech, et al. · The American Journal of Gastroenterology · 40

Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety

2022 · María Chaparro, Diana Acosta, et al. · The American Journal of Gastroenterology · 36

Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients

2018 · María Chaparro, Manuel Barreiro-de Acosta, et al. · Digestive Diseases and Sciences · 32

PDF

Prognostic Value of the Burden of Cytomegalovirus Colonic Reactivation Evaluated by Immunohistochemical Staining in Patients with Active Ulcerative Colitis

2018 · Ariadna Clos-Parals, Paula Rodríguez-Martínez, et al. · Journal of Crohn s and Colitis · 31

Long-term Comparative Efficacy of Cyclosporine- or Infliximab-based Strategies for the Management of Steroid-refractory Ulcerative Colitis Attacks

2014 · Juan E. Naves, Jordina Llaó, et al. · Inflammatory Bowel Diseases · 28

Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn’s Disease (Versus-CD): Data from the ENEIDA Registry

2023 · María José García, Montserrat Rivero, et al. · Journal of Crohn s and Colitis · 27

2024 · Carla J. Gargallo-Puyuelo, Elena Ricart, et al. · Clinical Gastroenterology and Hepatology · 24

PDF

Intravenous corticosteroids in moderately active ulcerative colitis refractory to oral corticosteroids

2014 · Jordina Llaó, Juan E. Naves, et al. · Journal of Crohn s and Colitis · 24

Improved outcome of acute severe ulcerative colitis while using early predictors of corticosteroid failure and rescue therapies

2016 · Jordina Llaó, Juan E. Naves, et al. · Digestive and Liver Disease · 20

Serial semi-quantitative measurement of fecal calprotectin in patients with ulcerative colitis in remission

2017 · Esther Garcia-Planella, Míriam Mañosa, et al. · Scandinavian Journal of Gastroenterology · 19

Prevalence and risk factors for colorectal adenomas in patients with ulcerative colitis

2017 · Jordi Gordillo, Yamile Zabana, et al. · United European Gastroenterology Journal · 15

Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry

2021 · Margalida Calafat, Míriam Mañosa, et al. · Journal of Crohn s and Colitis · 14

Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry

2022 · Yamile Zabana, Ignacio Marín-Jiménez, et al. · Journal of Clinical Medicine · 13

Relative adrenal insufficiency in severe acute variceal and non‐variceal bleeding: influence on outcomes

2015 · Isabel Graupera, Oana Pavel, et al. · Liver International · 13

Switching to a Second Thiopurine in Adult and Elderly Patients With Inflammatory Bowel Disease: A Nationwide Study From the ENEIDA Registry

2020 · Margalida Calafat, Míriam Mañosa, et al. · Journal of Crohn s and Colitis · 11

Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA

2024 · Celia Gómez-Labrador, Elena Ricart, et al. · Pharmaceutics · 8

PDF

How and when should NSAIDs be used for preventing post-ERCP pancreatitis? A systematic review and meta-analysis

2013 · I. Puig, X. Calvet, et al. · Pancreatology · 8

Works count: 109

Citation count: 1,178

H-index: 18

I10-index: 23